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Introduction: Recently, cell-based therapy has gained significant attention for the treatment of central nervous
system diseases. Although bone marrow stromal cells (BMSCs) are considered to have good engraftment potential,
challenges due to in vitro culturing, such as a decline in their functional potency, have been reported. Here, we
investigated the efficacy of rat BMSCs (rBMSCs) cultured under simulated microgravity conditions, for
transplantation into a rat model of spinal cord injury (SCI).
Methods: rBMSCs were cultured under two different conditions: standard gravity (1G) and simulated microgravity
attained by using the 3D-clinostat. After 7 days of culture, the rBMSCs were analyzed morphologically, with RT-PCR
and immunostaining, and were used for grafting. Adult rats were used for constructing SCI models by using a
weight-dropping method and were grouped into three experimental groups for comparison. rBMSCs cultured
under 1 g and simulated microgravity were transplanted intravenously immediately after SCI. We evaluated the
hindlimb functional improvement for 3 weeks. Tissue repair after SCI was examined by calculating the cavity area
ratio and immunohistochemistry.
Results: rBMSCs cultured under simulated microgravity expressed Oct-4 and CXCR4, in contrast to those cultured
under 1 g conditions. Therefore, rBMSCs cultured under simulated microgravity were considered to be in an
undifferentiated state and thus to possess high migration ability. After transplantation, grafted rBMSCs cultured
under microgravity exhibited greater survival at the periphery of the lesion, and the motor functions of the rats that
received these grafts improved significantly compared with the rats that received rBMSCs cultured in 1 g. In
addition, rBMSCs cultured under microgravity were thought to have greater trophic effects on reestablishment and
survival of host spinal neural tissues because cavity formations were reduced, and apoptosis-inhibiting factor
expression was high at the periphery of the SCI lesion.
Conclusions: Here we show that transplantation of rBMSCs cultured under simulated microgravity facilitates
functional recovery from SCI rather than those cultured under 1 g conditions.
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In the last decade, a variety of cell types, including human
neural stem cells [1], embryonic stem (ES) cell derivatives
[2,3], and adult bone marrow stromal cells (BMSCs) [4-6],
have been transplanted into the injured spinal cord of rats
or mice, to their neuroregenerative activities. These pre-
clinical studies showed that engrafted stem cells promote
substantial functional recovery after spinal cord injury
(SCI) through both cell-autonomous/cell-replacement and
paracrine/trophic effects [7]. BMSCs are suggested to have
the capacity to differentiate into neural lineages [8] and
are advantageous with regard to less-invasive harvest pro-
cedures and large cell yields. BMSCs are also clinically
attractive because they lend themselves to autologous
transplantation in humans. Neural-like cells derived from
BMSCs could be used in cell therapy for degenerative or
traumatic diseases of the central nerve system [9-11]; thus,
the efficacy of these cells as transplants has been investi-
gated for the treatment of SCI [4,6,12,13].
We have focused on culturing BMSCs under simula-
ted microgravity and reported its influence on important
cellular events, such as cell cycling, proliferation, and
differentiation [14-17]. Previous studies using human
mesenchymal stem cells and human hematopoietic pro-
genitor cells have indicated that simulated microgravity
suppresses cellular differentiation, while favoring cell
proliferation [16,18]. Our previous study showed that
culturing of mouse BMSCs under simulated micrograv-
ity enhances the survival percentage, through mainten-
ance of an undifferentiated state of pluripotent cells [17].
Moreover, in a mouse model of cerebral contusion, the
efficacy of grafting mice BMSCs into the damaged brain
appeared to be attributed not only to cells differentiating
into neuronal cells but also to the factors derived by the
grafted cells. These factors suppressed the formation of
a glial scar and enhanced the elongation of the axons. In
particular, mice BMSCs cultured under simulated micro-
gravity expressed CXCR4 on their cell membrane; this
expression was increased over cells grown under stan-
dard 1 g conditions, and the motor function of mice
receiving grafts of BMSCs cultured under simulated mi-
crogravity improved significantly. These advantages make
BMSCs cultured under simulated microgravity a strong
candidate for cell-transplantation therapy for SCI.
In this study, we investigated the morphologic changes
and trophic effects of rat BMSCs cultured under simu-
lated microgravity on neural migration and survival, and
on functional improvements after SCI in a rat model.
Materials and methods
All study protocols were approved by the Animal Testing
Committee Guidelines at Hiroshima University and/or the
regulations of Animal Testing Facility of the Hiroshima
University Natural Science Support Center. Animal careand handling procedures were in accordance with Na-
tional Institutes of Health guidelines.Preparation of rBMSCs
Bone marrow cells of 5-week-old female Fischer/F344
rats were obtained from the bilateral femoral and tibial
bones, and 1.0 × 107 cells were suspended in Dulbecco
modified Eagle medium, low glucose (Sigma-Aldrich
Co., Saint Louis, MO, USA), with 10% fetal bovine se-
rum (Thermo Fisher Scientific HyClone, South Logan,
UT, USA), penicillin (100 units/ml), and streptomycin
(100 μg/ml; both from Sigma-Aldrich) in 90-mm-diameter
culture dishes (Thermo Fisher Scientific Nunc A/S,
Roskilde, Denmark). Cells were maintained at 37°C with
5% CO2 in a humidified chamber, and the medium was
exchanged to eliminate floating cells after 48 hours. Rat
BMSCs (rBMSCs) adhering to the bottom of the culture
dish were used as culture cells.
To obtain a sufficient population of cells for the ex-
periment, two subcultures of rBMSCs were proliferated
and plated by using OptiCell (Thermo Fisher Scientific
Nunc A/S) at a density of 2.0 × 104 cells/cm2. At 70%
confluency, the cells were divided (day 0) and cultured
under two different conditions: standard gravity (group
1G) and microgravity attained using the 3D-clinostat
(group CL). After 7 days of culture, the rBMSCs were ana-
lyzed morphologically, with RT-PCR and immunostaining,
and were used for grafting.3D-clinostat
Microgravity conditions can be produced either by space
flight or by free fall; to simulate microgravity, we used a
3D-clinostat (Mitsubishi Heavy Industries, Ltd., Kobe,
Japan), as previously patented (undifferentiated pluri-
potent stem cell proliferation/differentiation regulation
method and system, patent 2001–197182, Japanese pub-
lished unexamined application 2003–9852, Foreign pa-
tent WO2004/061092 A1 PCT; US, EU, 2004). This
device produces an environment similar to that of outer
space (10-3 g) by rotating a sample around two axes, in-
tegrating the gravity vector with the temporal axis. This
is accomplished by rotation of a chamber at the center
of the device, resulting in uniform dispersion of the
gravity vector within a spherical volume, with a constant
angular velocity. These specific conditions produced a
simulated environment of 10-3 g in 10 minutes.Morphologic changes
Morphologic changes of the cells were examined by
using an inverted phase-contrast microscope (Eclipse TE
300; Nikon Co., Tokyo, Japan), and were recorded by
taking images at random.
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Cultured cells were collected by using ISOGEN (Nippon
Gene Co., Ltd., Toyama, Japan), and RNA was isolated
according to the manufacturer’s protocol. Reverse tran-
scription was performed with ReverTra Ace-α- (Toyobo
Co. Ltd., Osaka, Japan). By using cDNA as the template,
PCR was performed by using BD Advantage 2 PCR Kits
(BD Biosciences Clontech, Palo Alto, CA, USA). We
used Oct-4 as a pluripotency marker and CXC-chemo-
kine receptor 4 (CXCR4) as the cell-migration marker.
We also investigated the expression of neurotrophins
(nerve growth factor (NGF) and brain-derived neuro-
trophic factor (BDNF)). Glyceraldehyde-3-phosphate de-
hydrogenase (G3PDH) was used as a housekeeping gene.
The sequences of the primers as well as the PCR condi-
tions used are shown in Additional file 1: Table S1.Immunostaining of cell-migration marker
Fixed rBMSCs were stained by using an immunostaining
method and were examined by using a multifunctional
microscope (BZ-9000; KEYENCE Co., Osaka, Japan). For
CXCR4, a 400-fold dilution of monoclonal anti-CXCR4
(fusin; Santa Cruz Biotechnology, Santa Cruz, CA, USA)
was used as the primary antibody, followed by Alexa
Fluor 488 goat anti-mouse IgG (H + L) (Invitrogen Co.,
Carlsbad, CA, USA). For nuclear staining, a 500-fold di-
lution of 40,6-diamidine-2-phenylindole dihydrochloride
(DAPI; Kirkegaard & Perry Laboratories, Gaithersburg,
MD, USA) was used. Images were stored on a computer
for later analysis, and the percentage of positivity was
calculated by dividing the number of positive cells by
the total number of cells.Construction of a rat model of spinal contusion and cell
grafting
Adult female Fischer/F344 rats weighing 150 to 200 g
were purchased from Charles River Breeding Company
(Yokohama, Japan) and were used for constructing a
spinal-contusion model by using a weight-dropping me-
thod [13,19,20]. Rats were anesthetized, and a midline
linear incision was made over the T9 to T11 spinous
processes. By dissecting the bilateral paraspinal muscle
laterally, the laminae of T9 to T11 were exposed. Lamin-
ectomy was carried out at T10. A cylindrical brass
weight (10 g) was dropped down a stationary rod onto
an impactor rod that rested on surface of the T12 dorsal
dura mater. Spinal contusion was achieved with a force
of 50 g/cm. The rats that underwent SCI received forced
exercises for motor recovery of hindlimbs daily after the
surgical procedure. Prophylactic antibiotics were admin-
istered for 7 days after the surgical procedure, and the
bladders of these rats were expressed manually twice
daily until spontaneous urine voiding was achieved.Experimental groups and cell transplantation
Rats were grouped into three experimental groups for
comparison in our study; Group Control, in which PBS
was administered immediately intravenously after the
spinal contusion; Group 1G, which received intravenous
injection of rBMSCs of group 1G cells immediately after
spinal contusion; and Group CL, which received intra-
venous injection of rBMSCs of group CL cells immedi-
ately after spinal contusion.
Rats in groups CL and 1G received cellular grafting by
injection of 3.0 × 105 cultured cells diluted in 100 μl
PBS into a tail vein. For the evaluation of survival and
migration of BMSCs in vitro, the grafted rBMSCs were
labeled by using PKH-26 (Sigma-Aldrich) as per estab-
lished protocols [21]. Immunosuppressants were not used
in any animals.
Behavioral analysis
The Basso-Beattie-Bresnahan locomotor rating scale
(BBB scale) [19,22] and inclined-plane task score were
used to evaluate the hindlimb functional improvement
of treated animals with spinal cord contusion. The BBB
scale is a 22-point scale that systematically and logically
follows recovery of hindlimb function, and ranges from
a score of 0, indicative of no observed hindlimb move-
ments, to a score of 21, representative of a normal am-
bulating rodent [23]. The inclined-plane task score
assesses the maximum angle at which the animal could
maintain its position for 5 seconds on an inclined plane.
In this study, behavioral analysis was performed just be-
fore spinal injury, again every day from day 0 to 7, day
14, and day 21 after injury. All evaluations of motor
function were performed by an observer lacking know-
ledge of group identities.
Histologic and immunohistochemical analysis
At 3 weeks after transplantation, animals were deeply
anesthetized and transcardially perfused with 4% para-
formaldehyde for histologic and immunohistochemical
analyses. The injured spinal cords were freed from the
vertebral columns and cryoprotected in 30% sucrose.
Fixed spinal cords were embedded in Tissue-Tek O.C.T
compound (Sakura Finetechnical Co., Tokyo, Japan), fro-
zen in liquid nitrogen, and sliced coronally into 7-μm-
thick sections by using a cryostat (Leica Microsystems
GmbH, Wetzlar, Germany). The segments were moun-
ted on microscope slides to be used for hematoxylin and
eosin (H&E) staining, staining of neurofilament heavy
chain (NF-H) as a neural differentiation marker, and
staining of glial fibrillary acidic protein (GFAP) as a glial
differentiation marker. H&E-stained segments were ex-
amined under a multifunctional microscope (BZ-9000;
KEYENCE Co.), and the areas of injured cavities were
measured in group Control, group 1G, and group CL, by
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tional Institutes of Health, Bethesda, MD, USA). The
cavity area ratio of each group was calculated by dividing
the cavity area by the total coronally resected spinal
cord area.
The following primary antibodies were used: monoclo-
nal anti-neurofilament 200 (Sigma-Aldrich) for NF-H
and monoclonal anti-GFAP (Sigma-Aldrich) for GFAP.
Alexa Fluor 488 goat anti-mouse IgG (H+L; Invitrogen)
was used as the secondary antibody. Stained segments
were examined under a multifunctional microscope
(BZ-9000). Transplanted PKH-26 labeled cells were
also observed under this microscope.
Immunostaining of apoptosis-associated markers was
performed for the apoptosis-promoting marker Bcl-2-as-
sociated X protein (Bax), and for the apoptosis-inhibiting
markers B-cell CLL/lymphoma 2 (Bcl-2) and survivin. The
following primary antibodies were used: anti-Bax mono-
clonal antibody for Bax, anti-Bcl-2 polyclonal antibody for
Bcl-2, and anti-survivin polyclonal antibody (all; Santa
Cruz Biotechnology, Santa Cruz, CA, USA). Secondary
antibodies included enzyme-conjugated anti-mouse Bax
monoclonal antibody for Bax, enzyme-conjugated anti-
rabbit Bcl-2 polyclonal antibody for Bcl-2, and enzyme-
conjugated anti-rabbit survivin polyclonal antibody for
survivin (all, Santa Cruz Biotechnology). Mayer hemato-
xylin was used to stain nuclei. Stained segments were ex-
amined under a multifunctional microscope (BZ-9000),
and the positivity ratios calculated by dividing the number
of positive cells by the total number of cells.Statistical analysis
All data are expressed as mean ± SD of individual sam-
ples per group and were analyzed by one-way analysis
of variance by using the Statistical Package for Social
Sciences 19 software package for Windows (SPSS,
Chicago, IL, USA). Differences between the values of
two groups were assessed by using the Mann–Whitney
U test. A P value of <0.05 was considered statistically
significant.Figure 1 Morphologic changes of each group. Morphologic changes (A
microgravity (group CL) were changed to dome-like shape and were smallResults
Effects of simulated microgravity for rBMSCs
Cells of both groups showed a spindle and oval shape, but
the rBMSC morphology cultured under simulated micro-
gravity was changed to “dome like” shape, and the cells
were smaller than those cultured under 1 g (Figure 1A, B)
(See Additional file 2: Figure S1: morphologic change of
rBMSCs under simulated microgravity in detail). On day
7, expression of Oct-4 and CXCR4 mRNAs was observed
to be stronger in group CL cells (Figure 2A). No difference
was found between groups 1G and CL with regard to the
expression of NGF and BDNF mRNAs. The number
of cells positively stained for CXCR4 was significantly
higher (P < 0.01) in group CL cells than in group 1G
cells (Figure 2B).Effects of cell transplantation in SCI model rats: recovery
of motor function, cavity repair, and migration of
transplanted rBMSCs
In total, 29 adult female Fischer/F344 rats received a
standardized contusion of the spinal cord (11 each in
Control and 1G groups, seven in group CL). Dropping a
weight with a force of 50 g/cm resulted in complete
paraparesis, and rBMSCs of either group were trans-
planted immediately after the crush injury. For 21 days
after the crush injury, the BBB and inclined-plane task
scores gradually improved in all rats (Figure 3A, B).
Group CL showed the greatest improvement in motor
function from 5 to 21 days after SCI, as compared with
the controls and group 1G. The difference in the BBB
and inclined-plane task scores between group CL and
group 1G reached statistical significance by 5 days after
the injury.
The cavity formations, as assessed by H&E staining of
coronal sections at 21 days after SCI, were markedly
reduced in the groups that had received rBMSC trans-
plants (Figure 4A-C). Only very small cavities were iden-
tified within the SCI lesions in group CL; the cavity ratio
of group CL was also significantly reduced compared
with that of group Control (P < 0.05; Figure 4D).) group 1G; (B) group CL). The cells cultured under simulated
er than those cultured under 1 g (group 1G). Scale bars, 100 μm.
Figure 2 mRNA expressions of the graft cells. Effect of simulated microgravity on the graft cells. (A) mRNA expressions of Oct-4, CXCR4, NGF,
and BDNF at day 7. The expression of Oct-4 and CXCR4 mRNAs was observed to be stronger in group CL cells. Expression of the housekeeping
gene G3PDH was used to standardize expression. Immunostaining (B) indicated that the number of CXCR4-positive cells was significantly greater
(P < 0.01) in group CL than in group 1G (n = 5 per group). Data are expressed as mean ± SD. CXCR4-positive cell percentage was significantly
higher (P value < 0.01) in group CL than in group 1G.
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rBMSCs, labeled with PKH-26, had migrated into the
SCI lesions; the number of PKH-positive cells was notice-
ably higher in group CL than in group 1G (Figure 5A, B)
(see Additional file 3: Figure S2: the phase-contrast images
of rat uninjured spinal cord and contusional spinal cord
without cell transplantation). Furthermore, clustering of
the migrated cells was observed in the SCI lesion in group
CL (Figure 5B).Figure 3 Locomotor recovery. These graphs show the analysis of locomo
task score from the day on which SCI was induced (day 0) to 21 days later
from day 5 to day 21 after SCI (P value < 0.01). (B) The angle of the incline
(P value < 0.01).Effects of cell transplantation in SCI model rats:
immunohistochemical analysis
Transplanted cells showed higher expression of GFAP than
of NF-H in both groups 1G and CL. No statistically signifi-
cant difference was noted in the number of GFAP-positive
cells between the 1G and CL groups (Figure 5A, B).
Expression of the apoptosis markers Bax2, Bcl-2, and
survivin were examined in the frozen sections of each
group on day 21 (Figure 6). The positive cell percentagetor recovery as measured by the BBB score and the inclined-plane
. (A) BBB scores were significantly higher in group CL than in group 1G
d plane was also significantly greater in group CL from day 5 to day 21
Figure 4 Cavity formation after SCI. Cavity formation after SCI stained with hematoxylin and eosin (A) rat uninjured spinal cord, (B) group
Control, (C) group 1G and (D) group CL). Scale bars, 300 μm. The cavity formations (arrows) were markedly reduced in the groups that had
received rBMSC transplants. Only very small cavities were identified within the SCI lesions in group CL. The graph (D) shows the difference in the
volume of cavities at 21 days after SCI among group Control (n = 7), group 1G (n = 7), and group CL (n = 6). Data are expressed as mean ± SD.
The values of the cavity size were significantly different between group CL and group Control (P value < 0.05). Group C, n = 11; Group 1G,
n = 11; Group CL, n = 7.
Mitsuhara et al. Stem Cell Research & Therapy 2013, 4:35 Page 6 of 10
http://stemcellres.com/content/4/2/35for the apoptosis-promoting factor Bax was signifi-
cantly decreased in group CL compared with group
Control and group 1G. Moreover, the expression of the
apoptosis-inhibitory factor survivin was significantly in-
creased in group 1G and CL compared with the control.
Bcl-2 expression was not significantly different among the
groups.
Taken together, the findings indicate that transplant-
ation of the rBMSCs in group CL contributed to a signifi-
cant improvement of motor function and morphologic
features compared with the improvement observed in
group 1G.
Discussion
We report here the remarkable neuroregenerative effect
of rBMSCs cultured in simulated microgravity on func-
tional recovery after SCI; to our knowledge, this is the
first study in which rBMSCs cultured in simulated mi-
crogravity were transplanted into an SCI model.
Previously, BMSCs have been reported to exhibit dis-
tinct effects on the recovery of injured spinal cords and
to improve locomotion in SCI rats; moreover, cavity for-
mation in the spinal cord was reported to be reduced
when BMSCs were infused into the cerebrospinal fluid
with acute SCI [24,25]. To examine possible future clini-
cal applications of cells grown in simulated microgravity,we used a spinal-contusion model involving a weight-
dropping method. In this study, grafted rBMSCs pro-
moted functional improvement, which was accompanied
by the suppression of cavity formation 3 weeks after SCI.
As previously reported [13], functional recovery of the
spinal-contusion models by using a weight-dropping me-
thod was less prominent and reached a plateau during
the third week after SCI. In this study, we transplanted
cells immediately after a surgical procedure to examine
the therapeutic benefits of the transplanted cells con-
cerning the multiple pathogenic signals that function
synergistically during the early phase after SCI. The
present study confirmed possibilities that rBMSCs cul-
tured under simulated microgravity have the pluripo-
tency and the advantage as grafting cells for the early
phase of SCI repair.
Previous studies have shown that microgravity sup-
presses the differentiation of human osteoblast cells [15],
human hematopoietic progenitor cells [18], and rat myo-
blasts [16]. Simulated microgravity also allows novel cul-
ture methods for mouse ES cells that do not require
leukemia inhibitory factor or animal-derived supplements
[14]. The 3D-clinostat is a device that allows generation of
a multidirectional g force, resulting in an environment
with an average of 10-3 g [14,16]. Our previous study
showed that cells cultured in a 3D-clinostat exhibit
Figure 5 Immunostained images of each group at 21 days after transplantation. Phase-contrast microscopic images of spinal cord from
each group (a, e), and transplanted cells labeled with PKH-26 (b, f, g) are shown. In group CL, clustering of the migrated PKH-26-positive cells
was observed around the SCI lesion (f, g). Immunostained images of each group are shown © NF-H in group 1G, (d) GFAP in group 1G, (h) NF-H
in group CL, (i) GFAP in group CL). Green staining indicates cells positive for the differentiation marker. Yellow-staining cells indicate grafted cells
expressing each neural marker. Transplanted cells had a tendency to express higher levels of GFAP than NF-H in group 1G and in group CL
(c, d, h, i). Scale bars, 300 μm (b and f), and 100 μm (c, d, g, h, and i).
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growth inhibition through reduction of mitochondrial ac-
tivity [17]; moreover, simulated microgravity enhanced the
chemosensitivity of malignant glioma cells [27].
In the present study, simulated microgravity was con-
sidered to induce growth inhibition and to maintain
the undifferentiated state of rBMSCs, because the rBMSCs
cultured under simulated microgravity were smaller and
had a dome-like shape, and the expression of Oct-4
mRNA was observed only in group CL cells.
A recent study showed that when undifferentiated
ES cells are transplanted, they act in a neuroprotective
manner and exert antinociceptive and therapeutic effects
after excitotoxic SCI [28]. Another study showed that
transplantation of murine ES cells that had been undiffe-
rentiated into GABAergic neurons significantly inducedrecovery of sensorimotor function after traumatic brain
injury, whereas animals transplanted with astrocytes did
not show any recovery [29]. Several studies have shown
the superiority of using undifferentiated stem cells for
transplantation after SCI for facilitating functional recov-
ery [29-31]; the results of the present study were consist-
ent with the findings of other transplantation studies,
because simulated microgravity induced an undifferenti-
ated state in the grafted rBMSCs.
By using the specific SDF-1 receptor (CXCR4), we
found significant expression of the chemokine stromal-
cell-derived factor-1 (SDF-1) in rBMSCs cultured under
simulated microgravity. The interaction of SDF-1 with
CXCR4 mediates the homing of hematopoietic stem
cells to the bone marrow [32]; SDF-1 is also known to
induce migration of neural cells [30,33]. In this study,
Figure 6 Expression of apoptosis markers. Frozen sections were stained with apoptosis markers, Bax (B), Bcl-2 (C), and survivin (D), to examine
the neurotrophic effects activated by grafted cells against apoptosis. The graph shows the positive cell percentage around SCI lesion in the
frozen spinal cord sections (A) of each group (n = 6 per group). The number of Bax-positive cells was significantly decreased in group CL rats
compared with the control group (P value < 0.01) and group 1G (P value < 0.05). Moreover, the number of survivin-positive cells was significantly
increased in groups 1G and CL compared with the control (P value < 0.01; P value < 0.05). Bcl-2 expression was not statistically significantly
different between groups. Data are expressed as mean ± SD. Scale bars, 300 μm (A), 100 μm (B, C, and D).
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into the SCI lesion was markedly greater in group CL
and the cavity formation after SCI was markedly reduced
in group CL compared with group 1G. Our results sug-
gest that simulated microgravity mediated the extended
expression of CXCR4 in the rBMSCs, and that the inter-
action of SDF-1 with CXCR4 then facilitated the traf-
ficking of rBMSCs to the SCI site.
Several studies have shown that BMSCs differentiate in-
to neural cells, including astrocytes and neurons [6,34,35];
conversely, other studies have indicated that transplanted
BMSCs do not differentiate into neural cells in the spinal
cord [12,20]. Our previous study, by using a mouse model
of cerebral contusion, showed that the efficacy of grafting
mouse BMSCs was attributed not only to the cells differ-
entiating into neuronal cells but also to the factors re-
leased by grafted cells that suppressed the formation of a
glial scar and that enhanced the elongation of axons [17].
It has been suggested that transplanted BMSCs may not
survive long enough to be integrated into the spinal cord
tissue [12,36] and that BMSCs, despite their limited sur-
vival time, enhance tissue matrix formation and axonaloutgrowth in SCI by releasing diffusible neuroprotective
factors [6,25,30,34,37]. This probably contributed to the
distinct improvement of locomotor behavior as well as the
reduction of the cavity formation noted in our study. Al-
though, in our study, the transplanted rBMSCs expressed
the differentiation marker GFAP, it is unlikely that the effi-
cacy of rBMSCs for improving the injured spinal cord re-
lates to these cells forming spinal cord tissue, because of
the small number of rBMSCs used for transplantation.
It has been shown that stem cell transplantation can im-
prove neurologic function by several mechanisms, some
of which are neuroprotective effects on host neurons from
trophic factors secreted by transplanted cells, and the
reestablishment of functional neural networks through the
integration of transplanted cells [38,39]. All things consid-
ered, the beneficial effect may rather relate to the release
of neuroprotective factors by the BMSCs [40-42].
Neurotrophins are a family of proteins that are best
characterized by their modulation of survival, differenti-
ation, and apoptosis of cells in the nervous system, and
exogenously applied trophic factors, including BDNF,
IGF-1, NT-3, GDNF, and HGF, have been shown to be
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from BMSCs promote neurite extension and survival
in vitro, their roles in the functional recovery of SCI are
still largely unknown. In this study, we investigated the
expression of NGF and BDNF mRNAs in graft cells, but
found no difference between groups 1G and CL with
regard to the expression of these mRNAs. The mRNA
expressions of NGF and BDNF are only by a semiquan-
titative method. Therefore, to investigate the trophic
effect of the grafted rBMSCs, we analyzed apoptosis
markers in the SCI lesions, because SCI induces a series
of endogenous biochemical changes that lead to secon-
dary degeneration, including apoptosis. Mitochondrial
apoptosis mediated by p53 is likely to be an important
mechanism of cell death in SCI. Expression of p53 was
observed in neurons, oligodendrocytes, and astrocytes
after SCI, and upregulation of phospho-p53 and Bax,
and downregulation of Bcl2, were detected after SCI
[43]. In this study, the fact that the expression of the
apoptosis-promoting factor Bax significantly decreased
and that of the apoptosis-inhibitory factor survivin sig-
nificantly increased in group 1G and CL rats compared
with group Control, demonstrated the trophic, antiapop-
totic effect of the grafted rBMSCs. Apoptosis and free-
radical damage are the prominent processes involved in
secondary degeneration after SCI [43,44]. Our results
suggest that the grafted BMSCs immediately after injury
prevented the secondary degeneration and enhanced the
proliferation of the axons to a greater extent in group
CL rather than in group 1G.
Conclusion
rBMSCs cultured under simulated microgravity suggested
to be induced undifferentiated state and migration ability.
rBMSCs cultured under simulated microgravity had
greater trophic effects on reestablishment and survival of
host spinal neural tissues than those cultured under 1g,
and contributed to enhanced functional improvement
after SCI in vivo.
Additional files
Additional file 1: Table S1. Polymerase chain reaction primers and
conditions.
Additional file 2: Figure S1. The morphologic changes of rBMSCs
cultured under microgravity. On Day 4, the cells became smaller and
rounder. On Day 7, the cells became much smaller and dome-like in
shape. Scale bars, 100 μm.
Additional file 3: Figure S2. The phase-contrast images of rat spinal
cord. (A) Rat uninjured spinal cord. (B) Rat contusional spinal cord
without cell transplantation. Scale bars, 300 μm.
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